Company and Stock Identity

How DeepHealth Connects to the Public Market

Company structure
Wholly owned subsidiary of RadNet
Market access
Public parent: RadNet, Nasdaq: RDNT.
Stock name
RadNet, Inc.
Ticker and exchange
Nasdaq: RDNT
Research focus
Use RadNet filings to measure the digital-health business, then use FDA and clinical sources to verify the claims attached to DeepHealth and acquired products.

DeepHealth is not separately traded. It is the digital health and AI business of RadNet.

Dated Market Snapshot

Sep 28, 2026 7:39 PM ET

Last price
$71.81
Previous close
$70.79
52-week high / low
$85.84/$50.82
Market cap
5,651,250,025

Automated from Nasdaq. Check the exchange or investor-relations page for the current price.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... RadNet ... Public parent source

DeepHealth announces two FDA clearances for its breast imaging suite

RadNet said DeepHealth received clearances for breast arterial calcification assessment and prior-exam integration in its breast imaging products.

Why it matters: The update adds both a new clinical signal and longitudinal comparison. Buyers should read the actual clearance records for intended use and test performance in their own screening workflow.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Radiology AI, informatics, engineering, clinical science, regulatory affairs, product, implementation, and imaging operations.

Qualification signal: Imaging informatics, radiology workflow, clinical validation, or software medical-device experience is useful. Corporate roles may sit at DeepHealth or its RadNet parent.

Check current roles at DeepHealth. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
Primary use case
Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
Typical deployment
Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow

Evidence questions

  • Was the tool tested prospectively and independently on comparable equipment and patients?
  • What are sensitivity, specificity, false positive workload, and time-to-action effects?
  • How does performance vary by site, scanner, demographic subgroup, and disease prevalence?

Regulatory and workflow questions

  • Which FDA authorization covers the exact product version, modality, and intended use?
  • Who retains final clinical responsibility and how is disagreement with the AI handled?
  • What post-deployment monitoring and material update notification does the vendor provide?

Data and contract questions

  • Where are images and derived data processed and retained?
  • Which PACS, RIS, pathology, and EHR integrations are supported in production?
  • Can data be used for model improvement, and what controls govern secondary use?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources